La Negoziazione del Prezzo dei Farmaci Oncologici in Italia
This whitepaper analyzes the market benchmark role in negotiating oncology drug prices in Italy, highlighting key implications for clinical practice.
- Publisher
- IQVIA Solutions Italy
- Published
- Length
- 16 pages
- File
- 5.6 MB PDF
Download the full 16-page PDF
Free · 5.6 MB · Instant access after email
This whitepaper explores the negotiation process for oncology drug pricing in Italy, emphasizing the importance of market benchmarks. Key findings include:
- Analysis of the Italian negotiation process for oncology drugs.
- Impact of market benchmarks on pricing strategies.
- Clinical practice implications and sustainability concerns for the Italian National Health Service (SSN).
- Future perspectives and limitations of the current pricing negotiation framework.
Ready to read the full report?
Join 12,000+ pharma leaders getting deep industry analysis delivered weekly.
More whitepapers like this
Barriers and Facilitators to Use of Digital Health Tools by Healthcare Practitioners
This study identifies key barriers and facilitators impacting healthcare practitioners' use of digital health technologies during and before the COVID-19 pandemic.
Examining the Validity of External Controls Relative to Randomized Controls
This presentation discusses the validity of external controls in medical product development and their comparison to randomized controls.
Radiopharmaceuticals - EU-IN Horizon Scanning Report
This report outlines the current status, trends, and regulatory challenges in the field of radiopharmaceuticals in the EU.